Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Tokunaga

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Anticancer Research|July 1, 2015
Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective StudyMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
In Vivo (Athens, Greece)|April 28, 2025
Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102Toshifumi Yamaguchi, Motoki Yoshida, Koichi Taira, et al.
Breast (Edinburgh, Scotland)|July 17, 2023
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, et al.
Clinical Lung Cancer|January 2, 2013
Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancerMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
Journal of Neurosurgery. Pediatrics|November 16, 2019
Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer GroupKai Yamasaki, Chikako Kiyotani, Keita Terashima, et al.
Brain Tumor Pathology|June 24, 2022
Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan-McDermid syndrome: a case report and systematic reviewHaruki Yamashita, Yoshiki Arakawa, Yukinori Terada, et al.
Chemotherapy|June 13, 2017
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015Jun Yamamura, Norikazu Masuda, Daigo Yamamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2015
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialKazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, et al.
Cancer Medicine|April 9, 2024
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID)Hiroyuki Arai, Takashi Tsuda, Yu Sunakawa, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2020
Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trialKazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Anticancer Research|July 1, 2015
Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective StudyMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
In Vivo (Athens, Greece)|April 28, 2025
Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102Toshifumi Yamaguchi, Motoki Yoshida, Koichi Taira, et al.
Breast (Edinburgh, Scotland)|July 17, 2023
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, et al.
Clinical Lung Cancer|January 2, 2013
Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancerMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
Journal of Neurosurgery. Pediatrics|November 16, 2019
Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer GroupKai Yamasaki, Chikako Kiyotani, Keita Terashima, et al.
Brain Tumor Pathology|June 24, 2022
Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan-McDermid syndrome: a case report and systematic reviewHaruki Yamashita, Yoshiki Arakawa, Yukinori Terada, et al.
Chemotherapy|June 13, 2017
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015Jun Yamamura, Norikazu Masuda, Daigo Yamamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2015
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialKazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, et al.
Cancer Medicine|April 9, 2024
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID)Hiroyuki Arai, Takashi Tsuda, Yu Sunakawa, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2020
Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trialKazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, et al.
Pageof 6